Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?

• Torsten Christ,
• Marc D. Lemoine,
• Thomas Eschenhagen

Affiliations

Torsten Christ

Institute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf

Marc D. Lemoine

DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck

Thomas Eschenhagen

Institute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf